Renal Imaging

  • François Jamar
  • Raffaella Barone
Chapter
Part of the Medical Radiology book series (MEDRAD)

Abstract

The use of radioisotopes in studies of the urinary system is dedicated to three major goals: quantification of renal function, dynamic imaging (i.e. renography) and parenchymal scintigraphy. This chapter deals with the current status and recent achievements in these fields with particular emphasis on pharmacological interventions.

Keywords

Renal Artery Stenosis Renovascular Hypertension Acute Pyelonephritis Effective Renal Plasma Flow Single Photon Emission Computerize Tomogra 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Andoh TF, Burdmann EA, Fransechini N et al (1996) Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506. Kidney Int 50:1110–1117PubMedGoogle Scholar
  2. Anninga JK, Valdès Olmos RA, de Kraker J et al (1994) Technetium-99m dimercaptosuccinic acid and ifosfamide tubular dysfunction in children with cancer. Eur J Nucl Med 21:658–662PubMedCrossRefGoogle Scholar
  3. Bingham JB, Maisey MN (1978) An evaluation of the use of 99mTc-DMSA as a static renal imaging agent. Br J Radiol 51:599–607PubMedGoogle Scholar
  4. Blaufox MD (1991) Procedures of choice in renal nuclear medicine. J Nucl Med 32:1301–1309PubMedGoogle Scholar
  5. Blaufox MD, Aurell M, Bubeck B et al (1996a) Report of the radionuclides in nephrourology committee on renal clearance. J Nucl Med 37:1883–1888PubMedGoogle Scholar
  6. Blaufox MD, Middleton ML, Bongiovanni J et al (1996b) Cost efficacy of the diagnosis and therapy of renovascular hypertension. J Nucl Med 37:171–177PubMedGoogle Scholar
  7. Blaufox MD, Fine EJ, Heller S et al (1998) Prospective study of simultaneous orthoiodohippurate and diethylenetriaminepentaacetic acid captopril renography. The Einstein/Cornell Collaborative Hypertension Group. J Nucl Med 39:522–528PubMedGoogle Scholar
  8. Britton KE, Nimmon CC, Whitfield HN et al (1979) Obstructive uropathy: successful evaluation with radionuclides. Lancet I:905–907Google Scholar
  9. Bröchner-Mortensen J, Rödbro P (1976) Comparison between total and renal plasma clearance of (51Cr)EDTA. Scand J Clin Lab Invest 36:247–249Google Scholar
  10. Brown SCW, Upsdell SM, O’Reilly PH (1992) The importance of renal function in the interpretation of diuresis renography. Br J Urol 69:121–125PubMedGoogle Scholar
  11. Brown SCW (1994) Nuclear medicine in the clinical diagnosis and treatment of obstructive uropathy. In: Murray IPC, Ell PJ (eds) Nuclear medicine in clinical diagnosis and treatment, vol 1. Churchill Livingstone, Edinburgh, pp 271–293Google Scholar
  12. Brown T, Mandell J, Lebowitz RL (1987) Neonatal hydronephrosis in the era of sonography. Am J Roentgenol 148:959–963Google Scholar
  13. Bubeck B (1993) Renal clearance determination with one blood sample: improved accuracy and universal applicability by a new calculation principle. Semin Nucl Med 23:73–86PubMedGoogle Scholar
  14. Camacho V, Estorch M, Fraga G et al (2004) DMSA study performed during febrile urinary tract infection: a predictor of patient outcome? Eur J Nucl Med published online (DOI: 10.1007/s00259-003-1410-z)Google Scholar
  15. Carpenter CB (1990) Immunosuppression in organ transplantation. N Engl J Med 322:1224–1226PubMedGoogle Scholar
  16. Chachati A, Meyers A, Godon JP et al (1987) Rapid method for the measurement of differential renal function validation. J Nucl Med 28:829–836PubMedGoogle Scholar
  17. Chantler C, Garnett ES, Parsons V et al (1969) Glomerular filtration rate measurement in man by the single injection method using 51Cr-EDTA. Clin Sci 37:169–180PubMedGoogle Scholar
  18. Clarke SEM, Smellie JM, Prescod N et al (1996) Technetium-99m-DMSA studies in pediatric urinary tract infection. J Nucl Med 37:823–828PubMedGoogle Scholar
  19. Clorius JH, Schmidlin P (1983) The exercise renogram. A new approach documents renal involvement in systemic hypertension. J Nucl Med 24:104–109PubMedGoogle Scholar
  20. Conway JJ (1992) The “well tempered” diuretic renogram: a standard method to examine the asymptomatic neonate with hydronephrosis or hydroureteronephrosis. J Nucl Med 33:2047–2051PubMedGoogle Scholar
  21. De Sadeleer C, Bossuyt A, Goes E et al (1996) Renal technetium-99m-DMSA SPECT in normal volunteers. J Nucl Med 37:1346–1349PubMedGoogle Scholar
  22. De Sadeleer C, Tondeur M, Melis K et al (1998) A Belgian study on the reproducibility in reporting Tc-99m DMSA planar scintigraphy. Eur J Nucl Med 25:855 (abstract)Google Scholar
  23. Dondi M, Franchi R, Levorato M et al (1989) Evaluation of hypertensive patients by means of captopril enhanced renal scintigraphy with technetium-99m DTPA. J Nucl Med 30:615–621PubMedGoogle Scholar
  24. Dondi M, Fanti S, de Fabritiis A et al (1992) Prognostic value of captopril renal scintigraphy in renovascular hypertension. J Nucl Med 33:2040–2044PubMedGoogle Scholar
  25. Donker AJM, van der Hem GK, Sluiter WJ et al (1977) A radioisotope method for simultaneous determination of the glomerular filtration rate and the effective renal plasma flow. Nether J Med 20:97–103Google Scholar
  26. Donoso G, Kuyvenhoven JD, Ham H et al (2003) 99mTc-MAG3 diuretic renography in children: a comparison between F0 and F+20. Nucl Med Commun 24:1189–1193PubMedCrossRefGoogle Scholar
  27. Dubovsky EV, Russell CD, Bischof-Delaloye A et al (1999) Report of the radionuclides in nephrology committee for evaluation of transplanted kidney (review of techniques). Semin Nucl Med 29:175–188PubMedGoogle Scholar
  28. Eggers PW (1988) Effect of transplantation on the Medicare end-stage renal disease program. N Engl J Med 318:223–229PubMedGoogle Scholar
  29. Eggli DF, Tulchinsky M (1993) Scintigraphic evaluation of pediatric urinary tract infection. Semin Nucl Med 23:199–218PubMedGoogle Scholar
  30. Elliot WJ, Martin WB, Murphy MB (1993) comparison of two non-invasive screening tests for renovascular hypertension. Arch Intern Med 153:755–764Google Scholar
  31. English PJ, Testa HJ, Lawson RS et al (1987) Modified method of diuresis renography for the assessment of equivocal pelviureteric obstruction. Br J Urol 59:10–14PubMedGoogle Scholar
  32. Eshima D, Fritzberg AR, Taylor A (1990) 99m-Tc renal tubular function agents: current status. Semin Nucl Med 20:28–40PubMedGoogle Scholar
  33. Fawdry RM, Gruenewald SM, Collins LT et al (1985) Comparative assessment of techniques for estimation of glomerular filtration rate with 99m-Tc-DTPA. Eur J Nucl Med 11:7–12PubMedCrossRefGoogle Scholar
  34. Fjeldborg P, Bröchner-Mortensen J (1986) Determination of 51-Cr-EDTA clearance in infants by a single capillary blood sample. Scand J Clin Lab Invest 46:335–340PubMedGoogle Scholar
  35. Fommei E, Ghione S, Hilson AJW et al (1993) Captopril radionuclide test in renovascular hypertension: a European multicentre study. Eur J Nucl Med 20:617–623PubMedCrossRefGoogle Scholar
  36. Gacinovic S, Buscombe J, Costa DC et al (1996) Inter-observer agreement in the reporting of 99mTc-DMSA renal studies. Nucl Med Commun 17:596–602PubMedGoogle Scholar
  37. Gates GF (1982) Glomerular filtration rate: estimation from fractional renal accumulation of 99m-Tc-DTPA (Stannous). AJR 138:565–570PubMedGoogle Scholar
  38. George NJR, O’Reilly PH, Barnard RJ et al (1983) High pressure chronic retention. Br Med J 286:1780–1783Google Scholar
  39. George NJR, O’Reilly PH, Barnard RJ et al (1984) Practical management of patients with dilated upper tracts and chronic retention of urine. Br J Urol 56:9–12PubMedGoogle Scholar
  40. Geyskes GG, de Bruyn AJG. (1991) Captopril renography and the effect of percutaneous transluminal angioplasty on blood pressure in 94 patients with renal artery stenosis. Am J Hypertens 4:685S–689SPubMedGoogle Scholar
  41. Giblin JG, O’Connor KP, Fildes RD et al (1993) The diagnosis of acute pyelonephritis in the piglet using single-photon emission computerized tomography dimercaptosuccinic acid scintigraphy: a pathological correlation. J Urol 1150:759–762Google Scholar
  42. Gordon I (1987) Indications for 99mTc-dimercaptosuccinic acid scan in children. J Urol 137:464–467PubMedGoogle Scholar
  43. Gordon I (1990) Urinary tract infection in paediatrics: the role of diagnostic imaging. Br J Radiol 63:507–511PubMedGoogle Scholar
  44. Gordon I, Ransley PG, Hubbard CS (1987) 99m-Tc DTPA scintigraphy compared with intravenous urography in the follow-up of posterior urethral valves. Br J Urol 60:447–449PubMedGoogle Scholar
  45. Gordon I, Mialdea-Fernandez RM, Peters AM (1988) Pelviureteric junction obstruction. The value of a post-micturition view in 99m-Tc DTPA diuretic renography. Br J Urol 61:409–412PubMedGoogle Scholar
  46. Gordon I, Anderson PJ, Orton M et al (1991) Estimation of technetium-99m-MAG3 renal clearance in children: two gamma camera techniques compared with multiple plasma samples. J Nucl Med 32:1704–1708PubMedGoogle Scholar
  47. Gupta NK, Bomanji JB, Waddington W et al (1995) Technetium-99m-L, L-ethylenedicysteine scintigraphy in patients with renal disorders. Eur J Nucl Med 22:617–624PubMedCrossRefGoogle Scholar
  48. Ham HR, Piepsz A (1991) Estimation of glomerular filtration rate in infants and in children using a single-plasma sample method. J Nucl Med 32:1294–1297PubMedGoogle Scholar
  49. Hilson AJW (1991) The renal transplant perfusion index: where are we now? Eur J Nucl Med 18:227–228PubMedCrossRefGoogle Scholar
  50. Hilson AJW, Maisey MN, Brown CB et al (1978) Dynamic renal transplant imaging with Tc-99m DTPA (Sn) supplemented by a transplant perfusion index in the management of renal transplants. J Nucl Med 19:994–1000PubMedGoogle Scholar
  51. Homsy YL, Williot P, Danais S (1986) Transitional neonatal hydronephrosis: fact or fantasy? J Urol 136:336–340Google Scholar
  52. Homsy YL, Mehta PH, Huot D et al (1988) Intermittent hydronephrosis: a diagnostic challenge. J Urol 140:1222–12226PubMedGoogle Scholar
  53. Howman-Giles R, Uren R, Roy LP et al (1987) Volume expansion diuretic renal scan in urinary tract obstruction. J Nucl Med 28:824–828PubMedGoogle Scholar
  54. Huot SJ, Hansson JH, Dey H et al (2002) Utility of captopril renal scan for detecting renal artery stenosis. Arch Intern Med 162:1981–1984PubMedCrossRefGoogle Scholar
  55. Jafri RA, Britton KE, Nimmon CC et al (1988) Technetium-99m MAG3, a comparison with iodine-123 and iodine-131 orthoiodohippurate, in patients with renal disorders. J Nucl Med 29:147–158PubMedGoogle Scholar
  56. Jakobsson B (1997) Importance of timing when using technetium-99m-dimecaptosuccinic acid scan in urinary tract infection. In: Taylor A, Nally JV, Thomsen H (eds) Radionuclides in nephrourology. Society of Nuclear Medicine, Reston, VA, pp 185–189Google Scholar
  57. Jakobsson B, Nolstedt L, Svensson L et al (1992) Technetium-99m-DMSA scan in the diagnosis of acute pyelonephritis: relation to clinical and radiological findings. Pediatr Nephrol 6:328–334PubMedCrossRefGoogle Scholar
  58. Jamar F, Piret L, Wese FX et al (1992) Influence of ureteral status on kidney washout during 99m-Tc DTPA diuresis renography in children. J Nucl Med 33:73–78PubMedGoogle Scholar
  59. Jones DA, Lupton EW, George NJR (1990) Effect of bladder filling on upper urodynamics in man. Br J Urol 65:492–496PubMedGoogle Scholar
  60. Joseph DB, Young DW, Jordon SP (1990) Renal cortical scintigraphy and single photon emission computerized tomography (SPECT) in the assessment of renal defects in children. J Urol 144:595–597PubMedGoogle Scholar
  61. Kabasakal L, Atay S, Vural AV et al (1995) Evaluation of 99mTc-ethylenedicysteine in renal disorders and determination of extraction ratio. J Nucl Med 36:1398–1403PubMedGoogle Scholar
  62. Kaplan-Pavlovic S, Nadja C (1998) Captopril renography and duplex Doppler sonography in the diagnosis of renovascular hypertension. Nephrol Dial Transplant 13:313–317Google Scholar
  63. Kass EJ, Fink-Bennett D (1990) Contemporary techniques for the radioisotopic evaluation of the dilated urinary tract. Urol Clin North Am 17:273–289PubMedGoogle Scholar
  64. King LR, Coughlin PWF, Bloch EC et al (1984) The case for immediate pyeloplasty in the neonate with ureteropelvic junction obstruction. J Urol 132:725–728PubMedGoogle Scholar
  65. Kletter K, Nurnberger N (1989) Diagnostic potential of diuresis renography: limitations by the severity of hydronephrosis and by impairment of renal function. Nucl Med Commun 10:51–61PubMedGoogle Scholar
  66. Kopecky RT, Deaver TF, McAfee JG (1987) Furosemide augments the effects of captopril on nuclear studies in renovascular stenosis. Hypertension 10:181–188PubMedGoogle Scholar
  67. Krijnen P, Oei HY, Claessens RAMJ et al (2002) Interobserver agreement on captopril renography for assessing renal vascular disease. J Nucl Med 43:330–337PubMedGoogle Scholar
  68. Kuyvenhoven J, Piepsz A, Ham H (2003) When could the administration of furosemide be avoided? Clin Nucl Med 28:732–737PubMedGoogle Scholar
  69. Ladegofed J (1966) Measurements of the renal blood flow in man with the 133Xe washout technique. Scand J Clin Lab Invest 18:299–315Google Scholar
  70. Levey AS, Perrone RD, Madias NE (1988) Serum creatinine and renal function. Ann Rev Med 39:465–490PubMedCrossRefGoogle Scholar
  71. Levitt BGS, Kogan S, Reda E et al (1988) The dilated urinary tract in children. Br J Urol 61:413–419PubMedGoogle Scholar
  72. Li Y, Lee HB, Blaufox MD (1997) Single-sample methods to measure GFR with technetium-99m-DTPA. J Nucl Med 38:1290–1295PubMedGoogle Scholar
  73. Majd M, Rushton HG (1992) Renal cortical scintigraphy in the diagnosis of acute pyelonephritis. Semin Nucl Med 22:98–111PubMedGoogle Scholar
  74. Majd M, Potter BM, Guzzetta PC et al (1983) Effect of captopril on efficacy of renal scintigraphy in detection of renal artery stenosis. J Nucl Med 24:23 (abstract)Google Scholar
  75. Mann SJ, Pickering TG, Sos TA et al (1991) Captopril renography in the diagnosis of renal artery stenosis; accuracy and limitations. Am J Med 90:30–40PubMedCrossRefGoogle Scholar
  76. Merrick MV, Uttley WS, Wild SR (1980) The detection of pyelonephritic scarring in children by radioisotopic imaging. Br J Radiol 53:544–556PubMedGoogle Scholar
  77. Meyer G, Piepsz A, Kolinska J et al (1998) Technetium-99m mercaptoacetyltriglycine clearance values in children with minimal renal disease: can a normal range be determined? Eur J Nucl Med 25:760–765PubMedCrossRefGoogle Scholar
  78. Miralles M, Covas MI, Martinez-Miralles E et al (1997) Captopril test and renal duplex scanning for the primary screening of renovascular disease. Am J Hypertens 10:1290–1296PubMedCrossRefGoogle Scholar
  79. Moretti JL, Rapin JR, Saccavini JC et al (1984) 2,3-dimercaptosuccinic-acid chelates. 2. Renal localization. Int J Nucl Med Biol 11:275–279PubMedGoogle Scholar
  80. Müller-Suur R, Müller-Suur C (1989) Glomerular filtration and tubular secretion of MAG-3 in the rat kidney. J Nucl Med 30:1986–1991PubMedGoogle Scholar
  81. Müller-Suur R, Bois-Svensson I, Mesko L (1990) A comparative study of renal scintigraphy and clearance with technetium-99m-MAG3 and iodine-123-hippurate in patients with renal disorders. J Nucl Med 31:1811–1817PubMedGoogle Scholar
  82. Müller-Suur R, Magnusson G, Bois-Svensson I et al (1991) Estimation of technetium 99m mercaptoacetyltriglycine plasma clearance by use of one single plasma sample. Eur J Nucl Med 18:28–31PubMedCrossRefGoogle Scholar
  83. Myers BD, Ross J, Newton L et al (1984) Cyclosporine-associated chronic nephropathy. N Engl J Med 311:699–705PubMedGoogle Scholar
  84. Nally JW Jr, Chen C, Fine EJ et al (1991) Diagnostic criteria of renovascular hypertension with captopril renography. Am J Hypertens 4:749S–752SPubMedGoogle Scholar
  85. Nordyke RA, Tubis M, Blahd WH (1960) Use of radioiodinated hippuran for individual kidney function tests. J Lab Clin Med 56:438–445PubMedGoogle Scholar
  86. O’Reilly PH (1989) Functional outcome of pyeloplasty for ureteropelvic junction obstruction: a prospective study in 50 consecutive cases. J Urol 142:273–276PubMedGoogle Scholar
  87. O’Reilly PH (1992) Diuresis renography. Recent advances and recommended protocols. Br J Urol 69:113–120PubMedGoogle Scholar
  88. O’Reilly PH (2003) Standardization of the renogram technique for investigating the dilated upper urinary tract and assessing the results of surgery. BJU Int 91:239–243PubMedGoogle Scholar
  89. O’Reilly PH, Testa HJ, Lawson RS et al (1978) Diuresis renography in equivocal urinary tract obstruction. Br J Urol 50:76–80PubMedGoogle Scholar
  90. O’Reilly P, Aurell M, Britton K et al (1996) Consensus on diuresis renography for investigating the dilated upper urinary tract. J Nucl Med 37:1872–1876PubMedGoogle Scholar
  91. Parkhouse HF, Godley ML, Cooper J et al (1989) Renal imaging with 99Tcm-labelled DMSA in the detection of acute pyelonephritis: an experimental study in the pig. Nucl Med Commun 10:63–70PubMedGoogle Scholar
  92. Patel K, Charron M, Hoberman A et al (1993) Intra-end interobserver variability in interpretation of DMSA scans using a set of standardized criteria. Pediatr Radiol 23:506–509PubMedCrossRefGoogle Scholar
  93. Peters AM, Brown J, Crossman D et al (1990) Noninvasive measurement of renal blood flow with technetium-99m-DTPA in the evaluation of patients with suspected renovascular hypertension. J Nucl Med 31:1980–1985PubMedGoogle Scholar
  94. Picciotto G, Sargiotto A, Petrarulo M et al (2003) Reliability of captopril renography in patients under chronic therapy with angiotensin II (AT1) receptor antagonists. J Nucl Med 44:1574–1581PubMedGoogle Scholar
  95. Piepsz A, Ham HR, Roland JH et al (1986) Technetium-99m DMSA imaging and the obstructed kidney. Clin Nucl Med 11:389–391PubMedGoogle Scholar
  96. Piepsz A, Hall M, Ham R et al (1989) Prospective management of neonates with pelviureteric junction stenosis. Scand J Urol Nephrol 23:31–36PubMedGoogle Scholar
  97. Piepsz A, Gordon I, Hahn K et al (1993) Determination of the technetium-99m mercaptoacetyltriglycine plasma clearance in children by means of a single blood sample: a multicentre study. Eur J Nucl Med 20:244–248PubMedGoogle Scholar
  98. Piepsz A, Pintelon H, Ham HR (1994) Estimation of normal chromium-51 ethylene diamine tetra-acetic acid clearance in children. Eur J Nucl Med 21:12–16PubMedCrossRefGoogle Scholar
  99. Piepsz A, Tondeur M, Kinthaert J et al (1996) Reproducibility of technetium-99m mercaptoacetyltriglycine clearance. Eur J Nucl Med 23:195–198PubMedCrossRefGoogle Scholar
  100. Piepsz A, Blaufox MD, Gordon I et al (1999) Consensus of renal cortical scintigraphy in children with urinary tract infection. Semin Nucl Med 29:160–174PubMedGoogle Scholar
  101. Prigent A (1993) Diagnosis of renovascular hypertension: the role of captopril renal scintigraphy and related issues. Eur J Nucl Med 20:625–644PubMedCrossRefGoogle Scholar
  102. Rabito CA, Moore RH, Bougas C et al (1993) Noninvasive, realtime monitoring of renal function: the ambulatory renal monitor. J Nucl Med 34:199–207PubMedGoogle Scholar
  103. Radó JP, Bános C, Takó J (1967) Frusemide renography. Lancet ii:1419–1420Google Scholar
  104. Ramsay D, Belton I, Finlay D (1997) A review of captopril renal scintigraphy and its effect on patient management. Nucl Med Commun 18:631–633PubMedGoogle Scholar
  105. Roccatello D, Picciotto G, Rabbia C et al (1992) Prospective study of captopril renography in hypertensive patients. Am J Nephrol 12:406–411PubMedGoogle Scholar
  106. Russell CD, Rowell K, Scott JW (1986) Quality control of technetium-99m DTPA: correlation of analytic tests with in vivo protein binding in man. J Nucl Med 27:560–562PubMedGoogle Scholar
  107. Russell CD, Thorstad BL, Yester MV et al (1988) Quantitation of renal function with technetium-99m MAG3. J Nucl Med 29:1931–1933PubMedGoogle Scholar
  108. Russell CD, Taylor AT, Dubovsky EV (1996) Measurement of renal function with technetium-99m-MAG3 in children and adults. J Nucl Med 37:588–593PubMedGoogle Scholar
  109. Sapirstein LA, Vidt DG, Mandel MJ et al (1955) Volumes of distribution and clearances of intravenously injected creatinine in the dog. Am J Physiol 181:330–336PubMedGoogle Scholar
  110. Schillig S (1964) Indicator-dilution techniques in the estimation of renal blood flow. Am Heart J 68:675–681CrossRefGoogle Scholar
  111. Schreij G, van Es PN, van Kroonenburgh MJPG et al (1996) Baseline and postcaptopril renal blood flow measurements in hypertensives suspected of renal artery stenosis. J Nucl Med 37:1652–1655PubMedGoogle Scholar
  112. Setaro JF, Chen CC, Hoffer PB et al (1991) Captopril renography in the diagnosis of renal artery stenosis and prediction of improvement after revascularization. Am J Hypertens 4:698S–705SPubMedGoogle Scholar
  113. Shattuck LA, Eshima D, Taylor AT et al (1994). Evaluation of the hepatobiliary excretion of 99mTc-MAG3 and reconstitution factors affecting the radiochemical purity. J Nucl Med 35:349–355PubMedGoogle Scholar
  114. Sherman RA, Blaufox MD (1980) Clinical significance of non-visualization with 131I-hippuran renal scan. In: Hollenberg NK, Lange S (eds) Radionuclides in nephrology. Thieme, Stuttgart, pp 235–239Google Scholar
  115. Smellie JM, Normand ICS, Katz G (1981) Children with urinary tract infection: a comparison of those with and those without vesicoureteric reflux. Kidney Int 20:717–722PubMedGoogle Scholar
  116. Smellie JM, Ransley PG, Normand ICS et al (1985), Development of new renal scars. A collaborative study. Br Med J 290:1957–1960Google Scholar
  117. Smith HW, Goldring W, Chassis H (1938) The measurement of tubular excretory mass, effective blood flow and filtration rate in the normal human kidney. J Clin Invest 17:263–278Google Scholar
  118. Smith HW, Finkelstein N, Aliminosa L et al (1945) The renal clearances of substituted hippuric acid derivatives and other aromatic acids in dog and man. JCI 24:388–404Google Scholar
  119. Stoffel M, Jamar F, van Nerom C et al (1994) Evaluation of technetium-99m-L,L-ethylenedicysteine in renal transplant recipients: a comparative study with technetium-99m-mercaptoacetyltriglycine and iodine-125-orthoiodohippurate. J Nucl Med 35:1951–1958PubMedGoogle Scholar
  120. Stoffel M, Jamar F, van Nerom C et al (1996) Estimation of technetium-99m L,L-ethylenedicysteine clearance by simplified methods: correlation with effective renal plasma flow. Eur J Nucl Med 23:365–370PubMedGoogle Scholar
  121. Svetkey LP, Himmelstein SI, Dunnick NR et al (1989) Prospective analysis of strategies for diagnosing renovascular hypertension. Hypertension 14:247–257PubMedGoogle Scholar
  122. Taplin GV (1971) Kidney function and disease. In: Blahd WH (ed) Nuclear medicine, 2nd edn. McGraw-Hill, New York, pp 382–386Google Scholar
  123. Tarkington MA, Fildes RD, Levin K et al (1990) High resolution single photon emission computerized tomography (SPECT) 99mTechnetium-dimercaptosuccinic acid scintigraphy: a state of the art technique. J Urol 144:598–600PubMedGoogle Scholar
  124. Tauxe WH, Dubovsky EV, Kidd TJ et al (1982) New formulas for the calculation of effective renal plasma flow. Eur J Nucl Med 7:51–54PubMedGoogle Scholar
  125. Taylor A (2002) Renovascular hypertension: nuclear medicine techniques. Q J Nucl Med 46:268–282PubMedGoogle Scholar
  126. Taylor A, Eshima D, Christian PE et al (1987) Evaluation of Tc-99m mercaptoacetyl triglycine in patients with impaired renal function. Radiology 162:365–370PubMedGoogle Scholar
  127. Taylor A, Nally J, Aurell M et al (1996) Consensus report on ACE inhibitor renography for detecting renovascular hypertension. J Nucl Med 37:1876–1882PubMedGoogle Scholar
  128. Taylor A, Hansen L, Eshima D et al (1997) Comparison of technetium-99m-LL-Ec isomers in rats and humans. J Nucl Med 38:821–826PubMedGoogle Scholar
  129. Upsdell SM, Leeson SM, Brooman PJC et al (1988) Diuretic-induced urinary flow rates at varying clearances and their relevance to the performance and interpretation of diuresis renography. Br J Urol 61:14–18PubMedGoogle Scholar
  130. Upsdell SM, Testa HJ, Lawson RS (1992) The F-15 diuresis renogram in suspected obstruction of the upper urinary tract. Br J Urol 69:126–131PubMedGoogle Scholar
  131. Van Jaarsveld BC, Krijnen P, Derkx FH et al (1997) The place of renal scintigraphy in the diagnosis of renal artery stenosis. Fifteen years of clinical experience. Arch Intern Med 157:1226–1234PubMedGoogle Scholar
  132. Van Nerom CG, Bormans GM, de Roo MJ et al (1993) First experience in healthy volunteers with 99mTc-L, L-ethylenedicysteine: a new renal imaging agent. Eur J Nucl Med 20:738–746PubMedCrossRefGoogle Scholar
  133. Verbruggen AM, Nosco DL, van Nerom CG et al (1992) Technetium-99m-L,L-ethylenedicysteine: a renal imaging agent. I. Labeling and evaluation in animals. J Nucl Med 33:551–557PubMedGoogle Scholar
  134. Vidt DG (1991) The diagnosis of renovascular hypertension: a clinician’s viewpoint. Am J Hypertens 4:663S–668SPubMedGoogle Scholar
  135. Visscher CA, de Zeeuw D, Huisman RM (1995) Effect of chronic ACE inhibition on the diagnostic value of renography for renovascular hypertension: a preliminary report. Nephrol Dial Transplant 10:263–265PubMedGoogle Scholar
  136. Walser M, Drew HH, LaFrance ND. (1988) Creatinine measurements often yield false estimates of progression in chronic renal failure. Kidney Int 34:412–418.PubMedGoogle Scholar
  137. Whitaker RH (1973) Methods of assessing obstruction in dilated ureters. Br J Urol 45:15–22PubMedGoogle Scholar
  138. Williams ED (1992) Renal single photon computed tomography: should we do it? Semin Nucl Med 22:112–121PubMedGoogle Scholar
  139. Wong DC, Rossleigh MA, Farnsworth RA (1999) F+0 diuresis renography in infants and children. J Nucl Med 40:1805–1811PubMedGoogle Scholar
  140. Yen T-C, Chen W-P, Chang S-L et al (1996) Technetium-99m-DMSA renal SPECT in diagnosing and monitoring pediatric acute pyelonephritis. J Nucl Med 37:1349–1353PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2006

Authors and Affiliations

  • François Jamar
    • 1
  • Raffaella Barone
    • 1
  1. 1.Centre of Nuclear MedicineUniversity of Louvain Medical School, UCL 54.30BrusselsBelgium

Personalised recommendations